ATE512366T1 - Ms-verfahren zur evaluierung von glycanen - Google Patents

Ms-verfahren zur evaluierung von glycanen

Info

Publication number
ATE512366T1
ATE512366T1 AT08745856T AT08745856T ATE512366T1 AT E512366 T1 ATE512366 T1 AT E512366T1 AT 08745856 T AT08745856 T AT 08745856T AT 08745856 T AT08745856 T AT 08745856T AT E512366 T1 ATE512366 T1 AT E512366T1
Authority
AT
Austria
Prior art keywords
glycans
evaluation
things
identification
mixture
Prior art date
Application number
AT08745856T
Other languages
English (en)
Inventor
Carlos Bosques
Nathaniel Washburn
Xiangping Zhu
Ian Parsons
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE512366T1 publication Critical patent/ATE512366T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT08745856T 2007-04-16 2008-04-15 Ms-verfahren zur evaluierung von glycanen ATE512366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92367707P 2007-04-16 2007-04-16
PCT/US2008/060334 WO2008128221A1 (en) 2007-04-16 2008-04-15 Ms methods to evaluate glycans

Publications (1)

Publication Number Publication Date
ATE512366T1 true ATE512366T1 (de) 2011-06-15

Family

ID=39615678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08745856T ATE512366T1 (de) 2007-04-16 2008-04-15 Ms-verfahren zur evaluierung von glycanen

Country Status (14)

Country Link
US (1) US8043863B2 (de)
EP (1) EP2135091B1 (de)
JP (1) JP5116837B2 (de)
AT (1) ATE512366T1 (de)
AU (1) AU2008240074B2 (de)
CA (1) CA2682750A1 (de)
CY (1) CY1111811T1 (de)
DK (1) DK2135091T3 (de)
ES (1) ES2367210T3 (de)
HR (1) HRP20110610T1 (de)
PL (1) PL2135091T3 (de)
PT (1) PT2135091E (de)
SI (1) SI2135091T1 (de)
WO (1) WO2008128221A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2682750A1 (en) 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Ms methods to evaluate glycans
EP2702077A2 (de) 2011-04-27 2014-03-05 AbbVie Inc. Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US20150210753A1 (en) 2012-07-26 2015-07-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014179601A2 (en) 2013-05-02 2014-11-06 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2017117218A1 (en) 2015-12-30 2017-07-06 Momenta Pharmaceuticals, Inc. Methods related to biologics
CN113438953A (zh) 2018-10-11 2021-09-24 动量制药公司 采用高度唾液酸化IgG组合物的治疗
CA3125443A1 (en) 2018-12-31 2020-07-09 Momenta Pharmaceuticals, Inc. Methods of producing ustekinumab

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3383587B2 (ja) * 1998-07-07 2003-03-04 株式会社東芝 静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US20040147033A1 (en) * 2002-12-20 2004-07-29 Zachary Shriver Glycan markers for diagnosing and monitoring disease
JP4727577B2 (ja) * 2003-07-03 2011-07-20 ウオーターズ・テクノロジーズ・コーポレイシヨン 同位体組成および質量分析システムおよび方法
US7138228B2 (en) * 2003-09-05 2006-11-21 Regents Of The University Of California Protein O-sulfonation
US20060057638A1 (en) * 2004-04-15 2006-03-16 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
US20090012714A1 (en) * 2004-08-04 2009-01-08 Yasushi Ishihama Test of amino acid sequence constituting peptide using isotopic ratio
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
JP2009507212A (ja) * 2005-09-02 2009-02-19 オーストラリアン ヌークリア サイエンス アンド テクノロジー オーガニゼイション 同位体比質量分析計および同位体比の決定方法
CA2682750A1 (en) 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Ms methods to evaluate glycans

Also Published As

Publication number Publication date
PL2135091T3 (pl) 2011-11-30
US20100133430A1 (en) 2010-06-03
SI2135091T1 (sl) 2011-10-28
WO2008128221A1 (en) 2008-10-23
AU2008240074B2 (en) 2013-02-21
DK2135091T3 (da) 2011-09-19
EP2135091A1 (de) 2009-12-23
ES2367210T3 (es) 2011-10-31
CY1111811T1 (el) 2015-10-07
HRP20110610T1 (hr) 2011-10-31
PT2135091E (pt) 2011-09-01
CA2682750A1 (en) 2008-10-23
JP5116837B2 (ja) 2013-01-09
JP2010525327A (ja) 2010-07-22
EP2135091B1 (de) 2011-06-08
AU2008240074A1 (en) 2008-10-23
US8043863B2 (en) 2011-10-25

Similar Documents

Publication Publication Date Title
ATE512366T1 (de) Ms-verfahren zur evaluierung von glycanen
EA201270350A1 (ru) Способ идентификации и получения (r)-специфической омега-трансаминазы
EA201500316A1 (ru) Антагонисты толл-подобного рецептора 3
CL2009001263S1 (es) Maquina de afeitar.
UY32501A (es) Anticuerpo antagonista específico para el heterodímero alfa4-beta7
PH12013502230A1 (en) Multispecific antibodies
WO2011047087A3 (en) Protein detection via nanoreporters
WO2012009644A3 (en) Methods to identify synthetic and natural rna elements that enhance protein translation
EA201100300A1 (ru) Композиции и способы, предназначенные для направленного воздействия антител на белок c5 системы комплемента
WO2014071358A3 (en) Novel ntrk1 fusion molecules and uses thereof
CU20120095A7 (es) Antagonistas de pcsk9
MX373121B (es) Composiciones y metodos para el tratamiento de leucemia.
WO2009140039A3 (en) Synthetic antibodies
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
EA201201435A1 (ru) ГЕТЕРОДИМЕРНЫЕ АНТИТЕЛО-Fc-СОДЕРЖАЩИЕ БЕЛКИ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
GB2469962A (en) Automatic connections between application components
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
WO2010111299A3 (en) Synthetic antibodies
IN2012DE01026A (de)
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE532814T1 (de) Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
ECSP11011190A (es) Anticuerpos monoclonales anti-rhd
MX2011011623A (es) Antagonistas del receptor tipo toll 3.
EA201290804A1 (ru) Способ активации и сопряжения биомолекул

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2135091

Country of ref document: EP